Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Small Cell Lung Carcinoma 10Ovarian Neoplasms 9Carcinoma, Ovarian Epithelial 8Neuroblastoma 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Leukemia 5Fallopian Tube Neoplasms 5Uterine Cervical Neoplasms 4Myelodysplastic Syndromes 4Lung Neoplasms 4Leukemia, Myelomonocytic, Chronic 4Leukemia, Myeloid, Acute 4Unspecified Adult Solid Tumor, Protocol Specific 3Sarcoma 3Polycythemia Vera 3Neuroectodermal Tumors, Primitive, Peripheral 3Neoplasms 3Neoplasm Metastasis 3Lymphoma 3Ganglioneuroblastoma 3Carcinoma, Non-Small-Cell Lung 3Anemia, Refractory, with Excess of Blasts 3Thrombocythemia, Essential 2Primary Myelofibrosis 2Lymphoma, Large B-Cell, Diffuse 2Leukemia, Myelomonocytic, Acute 2Leukemia, Monocytic, Acute 2Leukemia, Megakaryoblastic, Acute 2Leukemia, Erythroblastic, Acute 2Carcinoma, Neuroendocrine 2

Interventions

sapanisertib 1mafosfamide 1Topotecan 1Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Meningeal Neoplasms × Topotecan × Clear all
NCT00001333 2008-03-04

Phase I Study of Intrathecal Topotecan

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
30 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Meningeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡